Skip to main content

Endocan/ESM-1 Antibody (E1)

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-41803

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-41803

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG1 kappa Clone # E1

Concentration

1 mg/ml

Product Specifications

Immunogen

Immunized with recombinant Human Endocan/ESM-1 (Uniprot#: Q9NQ30; Trp20-Arg184 (Uniprot#: Q9NQ30)

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1 kappa

Applications for Endocan/ESM-1 Antibody (E1)

Application
Recommended Usage

Western Blot

0.01-2ug/mL
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Protein A or G purified

Formulation

0.01M PBS, pH7.4, 50% glycerol

Preservative

0.05% Proclin 300

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: Endocan/ESM-1

Esm1 encodes a secreted protein which is mainly expressed in the endothelial cells in human lung and kidney tissues. The expression of this gene is regulated by cytokines, suggesting that it may play a role in endothelium-dependent pathological disorders. The transcript contains multiple polyadenylation and mRNA instability signals.

Alternate Names

ESM-1, ESM1, IGFBP-rp6

Gene Symbol

ESM1

Additional Endocan/ESM-1 Products

Product Documents for Endocan/ESM-1 Antibody (E1)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Endocan/ESM-1 Antibody (E1)

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...